Mariel Elena Boyd

Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis

Alexandra Snyder, Tavi Nathanson, Samuel A. Funt et al. · PLoS Medicine · 2017 · 367 citations · Full text

Life Sciences, Immunology, Oncology +17

DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma

Min Yuen Teo, Richard Bambury, Emily C. Zabor et al. · Clinical Cancer Research · 2017 · 279 citations

Medicine, Molecular Genetics, Oncology +17

Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer

Gopa Iyer, Arjun Vasant Balar, Matthew I. Milowsky et al. · Journal of Clinical Oncology · 2018 · 143 citations

Medicine, Oncology, Urology +17

Real‐world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non–small cell lung cancer

Sean Khozin, Rebecca A. Miksad, Johan Adami et al. · Cancer · 2019 · 138 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A phase 2 trial of buparlisib in patients with platinum‐resistant metastatic urothelial carcinoma

Victor McPherson, Brendan Reardon, Aravind Bhayankara et al. · Cancer · 2020 · 30 citations · Full text

Medicine, Oncology, Pharmacology +17